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ABSTRACT Proteins of molecular mass 46,000 (p46) and 34,000-39,000 (p36) daltons are
phosphorylated at tyrosine in Rous sarcoma virus-transformed chicken and mouse fibroblasts.
p46 has recently been identified as an isozyme of enolase but the function of p36 is unknown.
The expression of these proteins in various mouse and rat tissues has been examined . In most
tissues, except muscle, p46 is found at relatively constant levels. In muscle, a more basic,
related protein is present. In contrast, the abundance of p36 varies more widely from tissue
to tissue, suggesting that it has a function in some but not all differentiated cells. By SDS gel
electrophoresis and immunoblotting, high levels of p36 (60-120% of its relative abundance in
fibroblasts) were found in small intestine, lung, and thymus, and intermediate levels (20-50%)
were found in spleen, lymph nodes, and testes. No p36 was detectable in brain and muscle.
Where studied, p36 mRNA expression paralleled protein levels. The cell types within each
tissue expressing p36were identified by immunofluorescence and immunoperoxidase staining.
These cell types include all endothelial cells and fibroblastic cells examined, as well as various
epithelial cells, cardiac muscle cells, macrophages, and testicular interstitial cells. We were
unable to detect p36 in skeletal or smooth muscle cells, erythrocytes, nerve cells, or lympho-
cytes in any of the examined tissues. p36 appears to be concentrated in the terminal web
region of intestinal columnar epithelial cells.
Several of the acutely oncogenic RNA viruses encode trans-
forming proteins exhibiting tyrosine protein kinase activity
(36). A rapid increase in phosphotyrosine content of cellular
proteins accompanies transformation by these viruses (5, 15,
47, 59, 61). A similar increase in total cell phosphotyrosine
occurs in response to two growth factors, epidermal growth
factor (35) and platelet-derived growth factor (14). Modifica-
tion of cellular proteins by phosphorylation on tyrosine in-
duced by these agents is implicated in the transformation and
growth stimulation ofthe target cells. As putative participants
in the pathway(s) leading to altered growth states of the cells,
the identity and normal function ofthe substrates oftyrosine
protein kinases are of interest.
The identities of a few cellular targets of tyrosine protein
kinases are now known (20, 58). However, the function of
the first described substrate (52), a protein whose molecular
mass has been estimated from 34,000-39,000 daltons (15, 25,
52) remains a mystery. We will refer to this protein as p36.
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p36 is a highly conserved protein and has been recognized as
a substrate for tyrosine phosphorylation in avian, murine, rat,
human, and vole cells transformed by a variety of tumor
viruses encoding tyrosine protein kinases (11, 16, 17, 24, 25,
32, 42, 45, 49, 51), as well as in human A431 cells treated
with epidermal growth factor (26, 35) and in certain 3T3 cells
treated with platelet-derived growth factor (14). p36 is insig-
nificantly phosphorylated in untransformed cells (16, 23, 25,
45, 51) or in untreated A431 (17, 26) and 3T3 cells(14). The
phosphorylation induced by growth factors is particularly
interesting, since it shows that p36 can be phosphorylated by
tyrosine protein kinases in cells not transformed by acutely
oncogenic retroviruses. p36 can serve as a substrate for puri-
fied pp60v_s'c in vitro (25), indicating that it may be a direct
target of the virally coded kinase. Both in vivo and in vitro,
the phosphorylation of the polypeptide occurs at an identical
tyrosine residue (25). In vivo, p36 is also phosphorylated at a
serine residue(s) in transformed cells (19, 25, 51).
487As a first step in ascertaining the function ofp36, previous
studies sought to define its intracellular location in cultured
fibroblasts (2, 11, 18, 22, 33, 46, 50) and epithelial cells (46).
Cell fractionation experiments and indirect immunofluores-
cence microscopy have established an association of p36 with
the cytoplasmic face ofthe plasma membrane (2, 18, 22, 33,
46, 50). This location does not appear to change as a result of
phosphorylation in transformed cells (22, 33, 46). It has also
been reported that p36 is absent from some B cell lines (60).
This raises the possibility that p36 is expressed in only certain
cell types and that the identification of these cell types might
enable us to eliminate some candidate functions of p36.
Another cellular target of tyrosine protein kinases is a
46,000-dalton protein (p46) (15) that has recently been iden-
tified as an isozyme of the enzyme, enolase (20). The phos-
phorylated form of p46 has been detected in chicken embryo
fibroblasts transformed by Rous sarcoma virus, Fujinami
sarcoma virus, PRCII, Y73, and Esh sarcoma virus, and in
mouse 3T3 cells transformed by Rous sarcoma virus, Abelson
murine leukemia virus (A-MuLV)' and Snyder-Theilen feline
sarcoma virus (reference 16, and our unpublished data). p46
is not phosphorylated at tyrosine when 3T3 cells are treated
with growth factors, or in uninfected 3T3 or CEF, although a
charge variant of this enolase isozyme is constitutively phos-
phorylated, predominantly at serine (16). Prior to the identi-
fication of p46, information regarding its tissue distribution
was of interest.
In this study, we used antibodies raised against p36 and
p46 (19) to define the cell types that express the two proteins
in mice and rats. By examining tissues, rather than cultured
cell lines, we were able in most cases to examine terminally
differentiated cells. Our results indicate that p36 is detectable
in fibroblastic cells of connective tissue and in endothelial
cells in all the tissues examined. It is present at far lower levels
in, or absent from, all skeletal and smooth muscle cells, nerve
cells, erythrocytes, and most lymphocyte populations ana-
lyzed. On the other hand, proteins reacting with antibodies to
p46 were ubiquitous, as expected of a protein with an indis-
pensable function in cellular metabolism.
MATERIALS AND METHODS
Cells:
￿
The A-MuLV-transformed mouse NIH 3T3 fibroblast cell line,
ANN-1 (54), the rat skeletal muscle line, L6 (66), the mouse smooth muscle
cell line, BC3H1 (55), the RAW 264 and RAW 309 Cr.l mouse macrophage
lines (53) transformed by A-MuLV (from W. Raschke, La Jolla Cancer Re-
search Foundation), the thymic epithelial line, TEPI 1 (4), and the mouse T
cell lines, BW 5147 (40), TIMIA (37), S49.1TB (37), SAKRTLS (38),
AKR1.G.1 (38), and EL 4.G.1 (39) were grown in DME supplemented with
10% calf serum. LS cells were obtained from D. Schubert (The Salk Institute)
and plated at 5 x 10° cells/60-mm dish. They fused spontaneously after l wk
in culture. Unfused, dividing cells were killed by the addition of 0.5 ug/ml
cytosine arabinoside. Myotubes were collected 2 wk later. BC3H1 cells were
kindly provided in both their undifferentiated and differentiated state by J.
Patrick (The Salk Institute). The 18.81 line of A-MuLV-transformed mouse
pre-B cells (62) and the WEHI 231 line of mouse B lymphoma cells (from W.
Raschke) (64) were maintained in DME supplemented with 10% fetal calf
serum and 10-5 M 2-mercaptoethanol. The T cell lines and TEPI I cells were
from J. Lesley and C. MacLeod respectively (The Salk Institute). C. MacLeod
also provided cell extracts from the T cell lines SL12-1, SL124, SL12-9, SL2-
2, SL2-4, SL3-2, and SL3-4 (C. MacLeod, unpublished results), as well as from
SAK8 (29) and W7TB (6). The rat pheochromocytoma cell line, PC12 (34)
(from D. Schubert), was grown in DME supplemented with 10% newborn calf
serum and 5% horse serum. They differentiated afteraddition ofthe ß-subunit
'Abbreviations used in this paper: A-MuLV, Abelson murine leuke-
mia virus; EN, enolase; CEF, chick embryo fibroblast; EGF, epider-
mal growth factor.
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ofnerve growth factor, as described previously (34). Differentiated cells were
collected 6, 11, and 14 d afterinitial nerve growth factor treatment.
Antisera:
￿
Anti-p36 and anti-p46 sera were prepared against partially
purified chicken fibroblast proteins as previously reported (19). Antisera were
used at 1:200 dilutions for Western blots and immunoprecipitations. For use
in indirect immunofluorescence and immunoperoxidase staining, anti-p36
serum and preimmune serum were preabsorbed on 18.81 cells as already
described (46). Briefly, I(Y 18.81 lymphoma cells were fixed, permeabilized,
and resuspended in 0.5 ml PBS. 20 ul ofeither anti-p36 serum or preimmune
serum was added to the cells and allowed to incubate for 30-60 min. The
preabsorbed antisera were used at this 1 :25 dilution.
Western Blotting:
￿
Tissues were removed from mice, rinsed in Tris-
(hydroxymethyl)aminomethane (Tris)-buffered saline, and quickly homoge-
nized in ice-cold 20 mM Tris-HCl pH 8.8, I mM dithiothreitol, I mM EDTA,
and l % Trasylol(Mobay Chemical Corp., New York, NY) and frozen at -70°C
until their protein concentration was determined. Appropriate volumes were
then adjusted to contain 2% SDS, 20% 2-mercaptoethanol, 0.1 M Tris-HCI,
pH 6.8, 10% glycerol, (SDS gel sample buffer) and boiled for 2 min. Lympho-
cytes were isolated from thymus and spleen using Ficoll-Paque (Pharmacia
Fine Chemicals, Uppsala, Sweden). Tissue culturecells were rinsed in TBS and
dissolved in SDS gel sample buffer. Protein concentrations were determined by
the method of Lowry (44), after precipitation with trichloroacetic acid, or by
the method of Bradford (7). Nerve-specific enolase (EN) was from P. J.
Marangos (National Institute of Mental Health, Bethesda, MD). Protein
samples of 20 or 30 jug were resolved on SDS polyacrylamide gels (15%
acrylamide, 0.087% bis-acrylamide) and electrophoretically transferred to ni-
trocellulose filters as previously described (10, 63), except that the transfer
buffer included 0.1% SDS. After transfer, the blots were rinsed in buffer A (10
mM Tris-HCI pH 7.4, 0.9% NaCl, and 0.01% NaNA All the following
treatments were performed with gentle shaking at room temperature in the
bottom halfofa tissue culture flask. To block remaining protein binding sites,
blots were incubated sequentially for 2 h each with (a) 5% bovine serum
albumin, (b) 1% ovalbumin, and (c) 0.05% gelatin, all in buffer A. Antiserum
was diluted 1:200 in buffer A containing 0.25% gelatin and filtered. After 4 h
in antibody solution (20 ml for a blot 130 cm2) the blots were washed five times
in bufferA, two times in buffer A with0.05% Nonidet P-40 (Bethesda Research
Laboratories, Bethesda, MD), and five times again in buffer A over a period of
I h. To detect specifically bound antibody, the blots were incubated for 2 h
with I'll-Staphylococcus aureus protein A, specific activity 7 pCi/ug, (New
England Nuclear, Boston, MA) at a concentration of0.01 uCi/ml in buffer A
containing 0.25% gelatin. Blots were washed five times in buffer A, two times
in buffer A containing 0.05% Nonidet P-40, two times in buffer A containing
0.4% sodium N-lauroylsarcosine, and five times again in buffer A over a 1-h
period. Protein samples of 20 ug were resolved on two-dimensional gels as
previouslydescribed (15, 28). Westernblots oftwo-dimensional gels were made
and treated as described above. The blots were exposed to Kodak XAR5 x-ray
film, pre-exposed to 0.1-0.2 OD, with an intensifying screen, for up to 24 h at
-70°C.
RNA and In Vitro Translations: Mouse embryo mRNAs and
several mouse tissue mRNAs werea generous gift ofR. MüllerandJ. Tremblay
(The Salk Institute) (12). mRNA from tissue culture cells was prepared in the
following manner. Cells were lysed in 20 mM Tris-HC], pH 7.4, 5 mM MgCi2,
10 mM NaCl, 5 mM vanadyl ribonucleoside complex, and 0.28% Nonidet P-
40andtheir nuclei were removed by lowspeed centrifugation. The supernatant
was adjustedto 0.5% SDS, 10 mM EDTA, 0.1 M NaCl, and 1 mg/mlproteinase
K, incubated at 37°C for I h, and extracted with phenol/chloroform (1 :1, vol/
vol). The aqueous phase was precipitated with ethanol. Poly-A-containing
RNA was selected by passage through an oligo-dT cellulose column. Fetal and
adult muscle mRNAs were prepared from rat thigh muscle that was homoge-
nized in 50 mM Tris-HCl pH 7.4, 0.01 M M9Cl2, 0.1 M NaCl, and 0.25 M
sucrose. Debris was pelleted at 12,000 rpm for 10 min. The supernatant was
extracted several times with warm phenol/chloroform and the aqueous phase
was precipitated with ethanol. Poly-A-containing RNA was purified by oligo-
dTcellulose chromatography. Invitrotranslations were performed in a mRNA-
dependent reticulocyte lysate system as reported previously (48, 57). 1 Ag of
mRNA was used in each translation reaction. ["S]Methionine was present at
^-l mCi/ml in a final inaction volume of I I ul.
Immunoprecipitation : Immunoprecipitations were performed as
previously described (57) in "RIPA buffer" (57) with 2 mM EDTA included.
-5 x 105 cpm of in vitro translation productsand 2 x 106 cpm ofbiosynthet-
ically labeled polypeptides were immunoprecipitated in each reaction.
Biosynthetic Labeling:
￿
Cells were labeled by incubation with 50
uCi/ml ["S]methionine (>1,000 Ci/mmol, Amersham, Arlington Heights, IL)
at 37°C for 18 h in methionine-free DME supplemented with 5% fetal calf
serum and 5% DME. Cellswerewashed three times in Tris-buffered salineand
proteins were solubilized in either cold RIPA buffer or two-dimensional gel
lysis buffer (15, 28).Quantitation of p46 and p36 in ANN-1 Cells :
￿
['SS]Methio-
nine-labeledANN-1 cellextractswere quantitatively immunoprecipitated using
excess antibodies raised against p46 and p36 proteins . Immunoprecipitateswere
resolved in SDS polyacrylamide gels, the gels impregnated with 2,5-diphen-
yloxazole and p46 and p36 proteins detected by fluorography. Gel bands
corresponding to p46 and p36 were cut out and dissolved in 0 .2 ml 70%
perchloric acid and 0.4 ml 30% H202 overnight at 60°C before scintillation
counting. The ratio ofrecovered counts in each protein band to the total acid-
precipitable counts immunoprecipitated provided an estimate of the abun-
dances ofp36 and p46.
Immunofluorescence and Immunoperoxidase Staining :
Tissues were removed from rats and immediately frozen on dry ice inO.C.T .
Compound (Miles Laboratories, Elkhart, IN) . 4-,um thick sections were cut on
a cryostat at -20°C and mounted on glass slides. All subsequent treatments
were carried out at room temperature. Following each treatment, the mounted
sections were washed three times for 5 min in PBS. Sections were fixed in 2%
formaldehyde, 130 mM KCI, 16 .9 mM K2HP04, 3 .1 mM KH2P04, 5 MM
NaCl, 1 mM NaN,, 5mM MgC12 , and 1 mM EGTA pH 7 .5 for 30 min. For
immunoperoxidasestaining,sections were incubatedin0.05% phenylhydrazine
for 30 min before addition ofantibody. Sections were incubated with 20-30 pl
ofpreabsorbedanti-p36 serum or preabsorbed preimmune serum (both at 1:25
dilutions) for 30 min and either 30 g1 of a 1:15 dilution of affinity purified
fluorescein-conjugated goat anti-rabbit IgG (Sigma Chemical Co., St. Louis,
MO) for 30 min or 30 ul of a 1:50 dilution of affinity-purified horseradish
peroxidase-conjugated goat anti-rabbit IgG (Sigma Chemical Co.) for 90 min.
Sections stained for fluorescence were mounted under glass covershps in 90%
glycerol, 0 .2 M NaN,, and 10mM Tris-HCI, pH 7 .4 . They were viewed with a
Nikon Optiphot microscope with episcopic fluorescence attachment through a
Plan Apo 40X oil objective. Photographs were taken with Kodak Tri-X film.
Sectionsincubated with horseradish peroxidase-conjugated goat anti-rabbit IgG
were treated with diaminobenzidine (0.05% with 1 tit/ml 3% H202 included)
for up to 10 min and washed. Nuclei were then stained with hematoxylin for
1-2 min, rinsed twice with water, anddehydrated in ethanol and xylenes. The
sections were then mounted under glass coverslips with Permount (Fisher
Scientific Co ., Fairlawn, NJ) and inspected with a Nikon Optiphot microscope.
Photographswere taken through a Plan Apo 40X oil objective with appropriate
filters with Kodak Ektachrome 50 (tungsten) film.
Immunofluorescence of Intestinal Epithelial Cells :
￿
Intestinal
epithelial cells were prepared as described previously (8), exceptthat cells were
allowed to attach to poly-lysine-coated covershps at 37°C for 30-45 min before
fixation in ice-cold acetone for 5 min . The cells were fluorescently stained,
viewed, and photographed as described above.
RESULTS
Tissue Distribution ofp46 and p36
Antibodies raised to p46 and p36 proteins, partially purified
from chicken fibroblasts, were used to analyze the distribution
of homologous proteins in the mouse and rat. The sera used
were highly specific when used to immunoprecipitate [' SS]
methionine-labeled mouse fibroblast proteins . In addition,
the sera recognize the appropriate proteins in the mouse and
rat tissues examined, as judged by their SDS gel mobilities .
The contaminating proteins noted previously in immunopre-
cipitates prepared from chick cells (19) were much less evi-
dent ; presumably p36 and p46 are more highly conserved
between species than the contaminating proteins .
Immunoblotting was chosen to study the expression ofp46
and p36 in various mouse tissues. The alternative approaches
ofimmunoprecipitation ofbiosynthetically labeled tissues, or
competition radioimmunoassay, are both subject to errors if
the proteins studied are not soluble under the conditions for
antibody binding. Additionally, competition radioimmunoas-
say is inaccurate if there are any cross-reactive antibodies .
Animal tissues were homogenized and theirproteins dissolved
by boiling in a buffer containing SDS and mercaptoethanol
(see Materials and Methods) . Equal amounts of protein from
each tissue were subjected to SDS PAGE. The proteins were
electrophoretically transferred to nitrocellulose filters and the
blots were probed with anti-p46 or anti-p36 serum followed
by ["']I-labeled Staphylococcal protein A. Bound [`25]I-pro-
tein A was detected by indirect autoradiography. Represent-
ative blots are shown in Fig . 1 .
Quantitation of protein levels in the tissues was permitted
by the inclusion on each gel of samples containing different
amounts of protein from themouse fibroblast cell line, ANN-
1 . The levels of p36 and p46 in these cells were arbitrarily set
at 100% . In fact, p46 and p36 comprise about 0.12% and
0.05%, respectively of total protein in ANN-1 cells (see Ma-
terials and Methods). Densitometry of fluorographs exposed
for different lengths of time, as well as gamma counting of
"'I-containing bands cut from the Western blots, indicated
that the amount of anti-p46 serum bound was linearly pro-
portional to the amount of protein blotted in the range from
6% to 100% of the standard. Such a linear relationship did
not pertain in the case ofthe anti-p36 serum, but a calibration
curve was plotted for each experiment enabling estimation of
levels as low as 5% ofthe standard. Proteins from the murine
pre-B cell line, 18.81, previously shown to lack detectable
levels of p36 (60), were included on each gel as a negative
control for p36 expression.
FIGURE 1
￿
Western blots of adult mouse tissues . 20-30 p.g of pro-
tein from each tissue and from the 18.81 cell line were resolved on
15% polyacrylamide gels along with various amounts of protein
from the ANN-1 cell line . Proteins were electrophoretically trans-
ferred to nitrocellulose sheets, incubated with anti-serum raised
against p46 (A) or p36 (B) and then probed with 12'1-protein A.
Arrows point to p46 in A and p36 in B. Lanes 1, 1 .2 pg ANN-1 ;
lanes 2, 5 wg ANN-1 ; lanes 3, 10 wg ANN-1 ; lanes 4, 20 lAg ANN-1 ;
lanes 5, 18.81 ; lanes 6, brain ; lanes 7, liver; lanes 8, kidney ; lanes
9, small intestine ; lanes 10, lung; lanes 11, heart ; lanes 12, thigh
muscle ; lanes 13, spleen ; lanes 14, lymph nodes ; lanes 15, testes;
lanes 16, thymus ; lane 17, thymus cells teased from the organ.
Exposure times were 7 h with an intensifying screen at -70°C .
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found in all tissues examined, in accord with the identification
of p46 as an isozyme ofthe glycolytic enzyme, EN (20) (Fig .
1 A) . A lower molecular weight protein, also recognized by
anti-p46 serum, appears to have been a contaminant of the
immunogen (19) and is unrelated to p46 by tryptic peptide
analysis (unpublished data). In tissues with the highest rates
of glucose utilization (brain, heart, and skeletal muscle), the
46,000-dalton antigen was particularly abundant. The lowest
levels of p46 detected were in lung and spleen, where it was
present at 15-20% of the level in ANN-1 cells . In contrast,
Western blots probed with anti-p36 serum indicated that p36
expression varied more widely from tissue to tissue (Fig . 1 B) .
Brain, erythrocytes, and muscle lacked detectable levels ofthe
protein (<5% of the level in ANN-1 cells) while gut, lung,
and thymus had levels comparable to ANN-1 cells . The
average concentrations of both p46 and p36 relative to
ANN-1 cells are listed in Table I .
A common feature of those tissues containing abundant
p36 is their considerable lymphocyte populations . Since some
lymphocyte cell lines have high levels of p36 (60), a crude
fractionation of thymus and spleen was undertaken to deter-
mine whether the presence of p36 in those tissues could be
explained by high levels of p36 in lymphocytes. Thymus and
spleen were removed from a mouse and bisected. Blood cells
were teased from one half, freed of stroma by filtration, and
fractionated by gradient centrifugation . Equal amounts of
protein from the teased cells and the remaining tissue halves
were analyzed for the presence ofp36 by immunoblotting . In
each case p36 was found in the control half of the organ, but
at a much reduced level in the teased thymic cells (Fig . 2) .
TABLE I
p36 and p46 Expression in Mouse Tissues
* The levels of p36 and p46 in ANN-1 cells were arbitrarily set at 100% . The
actual amounts, determined as described in the Materials and Methods, are
0.05% and 0.12%, respectively .
= The range of four experiments.
sp36 and p46 mRNA abundance assessed on a scale of - (undetectable)
through ++ (abundance equal to ANN-1 mRNA), from two separate exper-
iments .
The range of two experiments.
" ND, not done .
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p36 was undetectable in the lymphocyte fraction or the other
blood cells (chiefly erythrocytes and granulocytes, data not
shown). By elimination, we conclude that p36 is in the cells
ofthe stroma of spleen and thymus .
p46-related Proteins Found in Specific Tissues
Our anti-p46 serum was raised against a protein exhibiting
a pI of 7.4 purified from fibroblasts (19). Minor charge
variants of this protein exist in fibroblasts, possibly due to
posttranslational modifications (19) . Analysis ofmouse tissues
by two-dimensional gel electrophoresis and visualization of
the proteins by silver staining showed that a protein with the
same mobilities as p46 was abundant in kidney, gut, brain,
liver, and thymus, less abundant in bone marrow and spleen,
and rare in skeletal muscle and heart (data not shown) .
Enolase (EN) is a dimer, with acidic brain-specific (y), basic
muscle-specific (0), and intermediate (a) subunits (3). Type
a-EN subunits have been found in many tissues, including
liver and brain, by gel electrophoresis under nondenaturing
conditions, but are absent from muscle (3) . Two-dimensional
gel analysis of in vitro translation products of muscle and
fibroblast mRNAs suggest that a- and O-EN may be different
gene products (data not shown) . Presumably type a-EN is our
"p46." Our Western blot data indicated, however, that there
are high levels of a 46,000-dalton protein reactive with anti-
p46 serum in skeletal muscle and heart . It therefore seemed
probable that our anti-p46 serum cross-reacted with the mus-
cle-specific ß form of EN and perhaps the brain-specific y
form as well . We investigated the cross-reactivity of the anti-
serum in the followingway.
["S]Methionine-labeled ANN-1 proteins were mixed with
unlabeled protein obtained from mouse muscle tissue. This
mix was resolved on a two-dimensional gel and immunoblot-
ted with anti-p46 serum . The major polypeptide identified by
FIGURE 2 Western blot of mouse thymus and spleen fractions .
Mouse thymus and spleen were bisected and teased to release
nonstromal cells . These cells were collected and freed of debris by
filtration . Equal amounts of protein from the intact tissues and from
the teased cells were analyzed for the presence of p36 by immu-
noblotting. An arrow indicates p36 . Lane 1, 3 FAg ANN-1 ; lane 2, 5
rug ANN-1 ; lane 3, 10 jig ANN-1 ; lane 4, 20 Fug ANN-1 ; lane 5,18.81 ;
lane 6, thymus; lane 7, thymus cells; lane 8, spleen ; lane 9, spleen
cells . Exposure time was 16 h with an intensifying screen at -70°C .
Levels
p36*=
p36
mRNA5
Levels
p46*t
p46
mRNA'
Controls
ANN-1 100% ++ 100% ++
18.81 <5% - 10-30% ++
Tissues
Brain <5% ± 120-140% ++
Liver <10% ± 20-35% +
Kidney 10-20% + 50-60% ++
Muscle <5% - 200% NO
Fetal muscle ND + ND ND
Heart 10-25% ND 85-105% ND
Spleen 20-25% + 15-20% +
Testes 30-50% + 45-55% +
Thymus 60-80% ++ 50-80% +
Lymph nodes 60-70% ND ND ND
Urinary tract 50-70% ND ND ND
Lung 90-110% ND 15-20% ND
Small intestine 100-120% ++ 30-50% +
Bone marrow 10-20%1 ND 20-40% -
Erythrocytes <5% 1 ND ND NDthe immunoblot exhibited the same molecular weight as the
fibroblast form but had a significantly more basic pl (data not
shown). This indicated that the antiserum cross-reacted with
the muscle specific form ofEN . The antiserum also reacted
with purified nerve-specific ti-EN subunits in an immunoblot
(data not shown) .
Tissue Distribution ofp46 andp36 mRNAs
To examine whether the abundances of p46 and p36 re-
flected the level ofmRNA coding for each, poly-A-containing
RNA was purified from various mouse tissues . The RNA was
translated in a mRNA-dependent reticulocyte lysate system .
Only undegraded RNA preparations, judged by their ability
to direct synthesis of high molecular weight proteins, were
used . Equal amounts of acid-precipitable ['SS]methionine-
labeled products from each mRNA were immnoprecipitated
with either anti-p46 or anti-p36 serum . Immunoprecipitates
were resolved on SDS polyacrylamide gels (Fig. 3) . The
mRNAs are classified as abundant (++), moderate (+), scarce
(±), or undetectable (-) (Table I). There appears to be a good
correlation between the amount of p46 and the level of p46-
specific mRNA . One exception to this relationship is the
18.81 cell line. In this case, the mRNA level was abundant
while the level of p46 was only 30% of that in ANN-1 cells.
Nevertheless, our results suggest that the level of p46 mRNA
is an important regulator ofEN abundance.
In general, the level ofmRNA for p36 correlates well with
the abundance of p36 itself . Brain, muscle, and liver exhibited
the lowest levels of both p36 and p36-specific mRNA . Thus,
p36 expression also appears to be regulated largely by the
level of its mRNA .
p36 Expression in Cell Lines
Several cell lines were examined for the expression of p36
either by immunoblotting, by biosynthetic [' SS]methionine
labeling followed by immunoprecipitation, or both . The spe-
cific method used in each case is listed in Table II . Some T
cell and B cell lines lacked the protein, consistent with the
low level of p36 in lymphocytes from thymus and spleen. The
only B cell line known to contain p36 is the pre-B cell line,
FIGURE 3 Estimation of p36- and p46-mRNA abundance by in
vitro translation . Poly-A containing RNAs, obtained from various
mouse tissues and from the cell lines, ANN-1 and 18.81, were
translated in a mRNA-dependent reticulocyte lysate system . Equal
amounts of acid precipitable cpm were immunoprecipitated with
anti-p46 serum (A) or anti-p36 serum (B) . The arrows point to p46
in A and p36 in B . In each case lanes 9 and 10 are from a separate
gel . Lanes 1, no added mRNA; lanes 2, ANN-1 ; lanes 3,18.81 ; lanes
4, kidney; lanes 5, liver; lanes 6, small intestine ; lanes 7, thymus ;
lanes 8, spleen ; lane 9 (A), brain ; lane 10 (A), 18.81 ; lane 9 (B),
ANN-1 ; lane 10 (B), brain . Exposure times were 15 d at -70°C .
TABLE II
Expression of p36 in Cell Lines
WB, Western blot.
IP, immunoprecipitation .
RAW 309 .1 .1 (60). Several T cell lines, differing in many
features including their stage of differentiation and mouse
strain ofderivation, were positive for p36 . The thymic epithe-
lial cell line, TEPI 1, contained p36, as expected of a cell line
derived from the thymic stroma . p36 was also detected in two
macrophage lines, RAW 309Cr .1 and RAW 264 .
The two myoblasts lines examined, BCH 1 and L6 , con-
tained p36 at approximately equal levels in both their differ-
entiated and undifferentiated stages . The differentiated myo-
tubes contained 10% myoblast contamination. ThePC12 line
contained p36 and upon treatment with nerve growth factor,
this levelincreased eightfold within 6 d . By day 14, theamount
had dropped to its original level . This suggests that develop-
mental regulation of p36 expression could be studied in this
cell line .
Developmental Regulation ofp36 Expression
Our detection of p36 in myoblasts and myotubes but not
in adult muscle suggested that p36 expression might be de-
velopmentally regulated. In vitro translation of poly-A-con-
taining RNA from rat fetal and adult muscle, followed by
immunoprecipitation with anti-p36 serum indicated that p36
mRNA was present in fetal muscle, while it was undetectable
in adult muscle (Fig. 4.4, lanes 8 and 9) . The decrease of p36
in muscle may thus occur at a late developmental stage that
is not reached within 2 wk ofmyotube formation in culture.
To investigate the question ofdevelopmental regulation on
a broader scale in the whole embryo, we obtained poly-A-
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Cell type Cell line
p36
expression
Method of
detection**
Fibroblast ANN-1 + WB and IP
Pre-13 lymphoma 18.81 - WB and IP
Muscle lines L 6 myoblast + WB and IP
L6 fused (2 wks) +
BCH1 +
BC3H1 differ- +
entiated
Pheochromocytoma PC12 + WB and IP
(nerve cell) PC12 + NGF Transient
increase
Macrophage lines RAW 264.7 + WB and IP
RAW 309 Cr .t +
T cell lines SL12-1 + WB
SL12-4 -
SL12-9 +
SL2-2 -
SL2-4 -
SL3-2 -
SL3-4 -
W7TB -
SAK.8 -
T cell lines SAKR TL - IP
S12 .1 .G .1
AKR1 .G .1 -
S49.1TB .2 .3 -
EL4.G .1 .4 +
BW5147G .1.4 +
TIM1 .4.G .1 .3 +
Thymic epithelium TEPI I + IP
B cell line WEHI 231 - WBcontaining RNA from different stages of mouse embryogen-
esis and from placenta. p36 was immunoprecipitated from in
vitro translation products and resolved on SDS polyacryl-
amide gels (Fig . 4A, lanes 1-7) . In embryos at day 11 (Fig.
4A) and day 12 (data not shown), the level of p36 mRNA
expression was considerably less than from day 13 on. Unfor-
tunately, embryos isolated at days 7 and 9 were contaminated
with placenta . Since placenta contains p36 mRNA, we could
not determine the level ofp36 mRNA in embryos before day
11 . Is is possible, however, that p36 expression is relatively
low until day 13 of mouse embryogenesis . Translation prod-
ucts were also immunoprecipitated with antiserum to p46
FIGURE 4 Immunoprecipitates of ["Slmethionine-labeled poly-
peptides synthesized in vitro from mouse embryo mRNAs . Poly-A
containingRNA was obtained from mouse embryos at various stages
of embryogenesis and from placenta and translated in a mRNA-
dependent reticulocyte lysate system . Equal numbers of acid pre-
cipitable cpm were immunoprecipitated with anti-p36 serum (A) or
anti-p46 serum (e) and the immunoprecipitates were analyzed by
SDS PAGE and fluorography . Arrows indicate p36 (A) and p46 (B) .
Lanes 1, placenta ; lanes 2, 7-d-old embryos; lanes 3, 9-d-old em-
bryos ; lanes 4, 11 -d-old embryos ; lanes 5, 13-d-old embryos; lanes
6, 15-d-old embryos ; lanes 7, 17-d-old embryos . Lanes 8 and 9 are
from a separate gel in which immunoprecipitates from translations
containing adult rat muscle mRNA (lane 8) and fetal rat muscle
mRNA (lane 9) were analyzed for the presence of p36. Exposure
times were 18 d for lanes 1-7 and 10 d for lanes 8 and 9 at -70°C .
Positive cell types
Epithelial cells
Columnar epithelial cells of small intestine*
Thymic epithelial cells*
Transitional epithelial cells of bladder*
Cuboidal epithelial cells of mammary gland ducts*
Amnion cells*
All examined endothelial cells'
Mesenchymal cells
Fibroblasts of all tissues examined'
Hematopoietic cells
Macrophages in lung'
Muscle cells
Cardiac muscle cells'
Other cells
Testis interstitial cells'
* Derived from endoderm.
' Derived from ectoderm .
' Derived from mesoderm .
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TABLE III
(Fig. 4B, lanes 1-7) . In this case, there was little variation in
expression with time and in contrast to p36 no difference was
found in the expression of p46 between days 11, 12, and 13 .
Cell Types Expressing p36
Having identified the tissues with highest levels of p36, we
wished to determine whether specific cell types within each
tissue expressed the protein and if so, identify them . Frozen
tissue sections 4 um thick were prepared from adult rats for
indirect immunofluorescence and immunoperoxidase stain-
ing. The results of this survey are summarized in Table III.
Examples of tissues stained by immunoperoxidase and im-
munofluorescence are shown in Figs. 5 and 6, respectively.
Specificity of staining was demonstrated by staining consec-
utive tissue sections in parallel with anti-p36 serum, preim-
mune serum, and second antibody alone . The sera were
absorbed first on fixed, permeabilized 18.81 lymphoid cells
(46) . Since these cells do not express p36, the absorption does
not remove antibodies recognizing p36, but does reduce nu-
clear fluorescence (46) . This nuclear fluorescence may indi-
cate the presence in the nonabsorbed sera of antibodies not
evident in immunoprecipitation experiments .
In all tissues analyzed, endothelial cells (note especially Fig.
5E) and fibroblastic cells of connective tissue stained specif-
ically . In addition, epithelial cells from various tissues (e.g.,
small intestine [Fig. 5, A and B, Fig . 6, A and B], thymus,
bladder [Fig. 5, G and H], and mammary gland), macro-
phages present in sections of lung, testicular interstitial cells,
and cardiac muscle cells (Fig. 5, C and D) gave positive
staining. Other epithelial cells (e.g., liver parenchymal cells,
seminiferous epithelium, columnar bronchiolar epithelium,
cuboidal epithelium of bile ducts, cuboidal and squamous
epithelia of kidney tubules, and skin epidermal cells), and fat
cells of the mammary gland appeared negative . Smooth and
skeletal muscle cells (Fig. 5, E and F), nerve cells, lympho-
cytes, and erythrocytes in all tissues analyzed stained weakly
or not at all, supporting the results of the immunoblotting
experiments .
Distribution ofp36 in Rat Tissue Cell Types by Immunofluorescence and Immunoperoxidase Staining
Negative cell types
Epithelial cells
Seminiferous epithelial cell's
Cuboidal epithelial cells of liver bile ducts'
Squamous and cuboidal epithelial cells of kidney tubules'
Columnar bronchiolar epithelial cells*
Epidermal cells of skin*
Liver parenchymal cells'
Mesenchymal cells
Fat cells of mammary gland'
Hematopoietic cells
Erythrocytes'
Lymphocytes of spleen and thymus'
Muscle cells
Smooth muscle cells in all examined tissues'
Skeletal muscle cells'
Other cells
Neurons in all examined tissues*FIGURE 5
￿
Indirect immunoperoxidase staining produced by anti-p36 serum in various rat tissues . Anti-p36 serum and preimmune
serum were preabsorbed on 18.81 lymphoma cells as described in Materials and Methods. Second antibody was affinity purified
horseradish peroxidase-conjugated goat anti-rabbit IgC . Nuclei were stained by hematoxylin and also appear black in the figure .
A, C, E, and G were stained with preabsorbed anti-p36 serum . B, D, F, and H were stained with preabsorbed preimmune serum .
A and Bare sections through the small intestine . Arrowheads indicate staining at the luminal border of the villi (V) in A; (L) lumen .
C and D are sections of cardiac muscle . Arrowheads point to the stained region along the muscle fiber in C . Note that the muscle
fiber (M) itself does not stain . E and F are thigh muscle sections . Note the strongly staining endothelial cells (indicated by the
arrows) lining blood vessels (BV) in E . G and Hare sections of urinary bladder . The arrowhead in G points to a fold of transitional
epithelium along the lumen (L) staining specifically. Bar, 25 um . x 200 .494
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be localized precisely within the cell due to technical difficul-
ties. In cardiac muscle cells, however, staining appeared to be
concentrated at or below the plasma membrane (Fig. 5 C),
that is, in the region of the sarcoplasmic reticulum. An
interesting staining pattern was seen in the small intestine.
p36 appeared to be concentrated at the luminal surface ofthe
columnar epithelial cells lining the villi (Fig. 5A and Fig. 6A).
Two specialized structures of these cells are located in this
same region, the microvilli and the terminal web. The termi-
nal web lies directly underneath the microvilli and is com-
posed ofa dense cytoskeletal network. To distinguish between
staining of the microvilli and the terminal web, single cell
suspensions ofthe epithelialcells were prepared and subjected
to indirect immunofluorescence staining (Fig. 6, C-E, and
G). These images were compared with those obtained using
Nomarski optics (Fig. 6 G). We cannot differentiate between
staining of membrane or staining ofcytoskeletal structures in
this region.
DISCUSSION
The function ofa major substrate of tyrosine protein kinases,
p36, remains unknown although an association with the inner
surface of the plasma membrane of some cultured cell lines
has been established (2, 18, 22, 33, 43, 46, 50). To gain
additional information as to the possible functions of the
protein, we have determined the tissue distrubution of p36 in
the mouse and rat by biochemical and immunocytochemical
techniques. Simultaneously, we examined the tissue distribu-
tion of p46, another substrate of tyrosine protein kinases,
which has recently been identified as a form of the glycolytic
enzyme, EN (20). Knowledge of the tissue distribution of a
protein might provide valuable insight as to its possible func-
tion. One would predict that a glycolytic enzyme would be
ubiquitous, with highest expression in skeletal muscle, heart
muscle, and brain, tissues in which glucose is metabolized at
a high rate. Indeed, the pattern of p46 expression we obtained
from Western blotting correlated with that prediction. In
contrast, it is difficult to perceive a theme underlying p36
expression. It was detected in endothelial cells, in fibroblastic
cells, macrophages, heart muscle cells, testicular interstitial
cells, and certain epithelial cells. It was present at very low
levels or absent from skeletal and smooth muscle cells, nerve
cells, erythrocytes, and lymphocytes.
A potential complication emerged from our analysis of the
tissue distribution of p46. Examination of tissue proteins by
two-dimensional gel electrophoresis followed by silver stain-
ing had indicated that a protein corresponding to fibroblast
p46 was rare in skeletal muscle and heart. Analysis of one-
and two-dimensional immunoblots of muscle protein re-
vealed that our antiserum reacted with the muscle isozyme of
EN, as well as the form found in fibroblasts and other tissues
(p46). If the antiserum were specific for p46, and had not
recognized the muscle isozyme, a less uniform distribution of
p46 would have been apparent. With regard to p36, this
example emphasizes the possibility that there might be pro-
teins related to p36 in structure and function but not recog-
nized by our anti-p36 serum, in those cells where p36 is
undetectable.
The wide range in the levels of p36 expression between
tissues found by Western blotting suggested that p36 was
probably not present in all cell types in the animal and
confirmed a prediction of previous work (27, 60) that p36
distribution would not be ubiquitous. In cultured fibroblasts,
p36 is a relavively abundant protein, comprising 0.2-0.25%
of the protein in primary chicken fibroblasts (19, 51) and
-0.05% in the mouse fibroblast line, ANN-1 . The level in
certain differentiated cell types of the mouse and rat must
exceed this because certain tissues surpass this level, while
only specific cellswithin the tissue gave a strong immunohis-
tochemical reaction with anti-p36 serum. For example, whole
thymus contained high levels of p36, but both immunofluo-
rescence and physical separation of cells showed that most of
the p36 was present in the quantitatively fewer stromal cells
rather than the lymphocytes. p36 is therefore a major protein
component of certain cells.
The expression ofp36 and p46 may be controlled primarily
by the concentrations of their respective mRNAs. For both
proteins, there was good correlation between the level of
protein in a given tissue and the level of its corresponding
mRNA, determined by in vitro translation and immunopre-
cipitation. It is interesting to note that the tissue distribution
ofp36 does not coincide with the tissue distributions ofknown
tyrosine protein kinases for which p36 is a substrate. When
the level of pp60'- in various tissues was determined by
measuring its enzymatic activity in an immunoglobulin pro-
tein kinase assay, brain exhibited the highest activity (21, 41)
followed by kidney, lung, muscle, and connective tissue.
Immunoprecipitation shows that the c-abl gene product is
abundant in thymocytes (65). Poly-A-containing RNA cor-
responding to the c-yes and c-ros genes is expressed at high
levels in kidney and RNA corresponding to the c-fps gene is
most abundant in bone marrow (56). The distribution ofthe
EGF receptor, reported to possess tyrosine protein kinase
activity (9, 13), also differs from that of p36. By IZSI-EFG
binding studies on mouse embryo tissues (days 11-18), EFG
receptor was present in decreasing order in amnion, lung,
FIGURE 6
￿
Indirect immunofluorescent staining produced by anti-p36 serum in the small intestine. Anti-p36 serum and preimmune
serum were preabsorbed on 18.81 lymphoma cells and incubated with frozen sections of rat small intestine as described in
Materials and Methods. Second antibody was affinity purified fluorescein-conjugated goat anti-rabbit IgG. (a) Villi of small intestine
stained with anti-p36 serum; (b) villi of small intestine stained with preabsorbed preimmune serum. Note the staining along the
luminal edge of the villi in a. Bar, 12 um. x 200. Columnar epithelial cells were dissociated from the small intestine, fixed,
permeabilized, and stained as described in Materials and Methods. (c) A small clump of cells stained with preabsorbed anti-p36
serum; (d) a similar group of cells stained with preabsorbed preimmune serum. The luminal side of the cells is up in each case.
Again, note the staining along the luminal edges of the cells in c. (e) A single columnar epithelial cell stained with preabsorbed
anti-p36 serum; (f) same field as shown in d viewed by Nomarski optics. Note the microvillar region at the left edge of the cells.
(g) This panel shows a composite of another single columnar epithelial cell. The left side of the panel shows the cell stained with
preabsorbed anti-p36 serum . The right side of the panel is the Nomarski image of the cell. Note that the microvilli extend beyond
the stained crescent which is in the area of the terminal web. Bars in C-G, 4 Am . x 200.
GOULD ET AL .
￿
Tissue Distribution ofp46 and p36
￿
495liver, brain, and heart (1). Adult heart contains higher levels
of p36 than does either liver or brain, although it may not be
pertinent to compare the adult situation with that of the
embryo. Also, one can imagine that regulation ofsome aspect
of cell physiology by p36 could occur at two levels-expres-
sion of p36 and, potentially, modification of p36 function by
phosphorylation.
The presence of p36 and p36 mRNA in some tissues but
not others implies developmental regulation. p36-specific
mRNA was not detected in adult muscle, in contrast with the
abundance of p36-specific mRNA in fetalmuscle, and ofp36
in primary cultures of chicken myoblasts (42) and rat myo-
blast cell lines. Even after 2 wk of fusion L6 cells continue to
express p36, suggesting that it is not simply fusion that triggers
the decline in p36-specific mRNA but rather a later event,
such as contact by nerves. It is also possible that the in vitro
model is not an accurate reflection of the in vivo situation.
Many, but not all, lymphoid cell lines express p36, but p36
was not detected in freshly-prepared thymic or splenic lym-
phocytes. All other cultured cellsanalyzed express p36. Thus,
p36 expression may be turned on when cells are put into
culture. In any case, the decrease of p36 in muscle is contrary
to the apparent overall pattern of p36 developmental regula-
tion. In the whole mouse embryo, p36 mRNA expression is
low on days 11 and 12 and significantly higher in laterstages.
Because of placental contamination, p36 mRNA expression
could not be determined in embryos isolated before day 11,
but it is possible that, in general, p36 expression is low
throughoutearly development.
Interpretation of immunofluorescence and immunoperox-
idase staining data relies on the specificity of the antiserum.
Our anti-p36 serum is not monospecific, although when used
against mouse and rat tissues, p36 is the major immunoreac-
tive protein. Thus, serum used for immunofluorescence and
immunoperoxidase staining was preabsorbed with fixed and
permeabilized cells that do not contain detectable p36. Stain-
ing exhibited with this preabsorbed serum is blocked by the
addition of excess purified p36 (46). An additional argument
for the specificity ofthe preabsorbed serum is the coincidence
ofits staining pattern in fibroblasts with that ofa monoclonal
antibody prepared to p36 (33) and with other polyclonal
antibodies raised against purified p36 (43, 50). In most re-
spects, our data on the expression of p36 in rodent tissues
resemble the data of Greenberg et al. (31) on the expression
ofthe homologous protein in chicken tissues.
It was not possible to ascertain the precise intracellular
location for p36 by immunofluorescence or immunoperoxi-
dase staining offrozen tissue sections in most ofthe positively
staining cells. With fluorescent stained sections, it is often
difficult to distinguish the cell type staining positively, let
alone the intracellular distribution of a protein. Immunoper-
oxidase staining has the advantage of allowing one to distin-
guish cell types easily but the brown precipitate, indicative of
positive staining, often covers the entire cell. Both procedures
are limited to detecting only populations ofantigen which are
accessible to antibody. Immunoelectron microscopy would
be needed to gain a more detailed picture. Two instances
where p36 couldbe localized within the cell were heart muscle
cellsand brush border cells of the small intestine.
In heart, the staining appeared along the edge ofthe cell by
both immunofluorescence and immunoperoxidase staining.
Staining was not evident within the muscle fibers. The thick-
ness and ruffled characteristic of the stained region suggested
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that it may represent the sarcoplasmic reticulum. This local-
ization within cardiac muscle cells may thus be analogous to
the plasma membrane localization within fibroblasts.
In small intestine, the luminal edges of the columnar epi-
thelial cells lining the villi stained exclusively with both im-
munofluorescence and immunoperoxidase procedures. Puri-
fied intestinal columnar epithelial cellsdo have an increased
amount of p36 per microgram of protein by Western blot
analysis in comparison to whole gut (data not shown). It is
quite possible that the bulk of p36 in the gut is present in the
columnar epithelial cells. Within these cells, immunofluores-
cence staining shows that p36 is localized primarily in the
terminal web region. In part, this apparent localization may
merely indicate better accessibility of the antigen to the anti-
body. The crescent-shaped staining pattern given by p36 in
columnar epithelial cells is shared with the spectrin-like pro-
tein found in chicken intestine, TW 260/240 (30). This co-
localization is especiallyintriguing as other investigators have
recently noted similar staining patterns by anti-p36 and anti-
spectrin sera in cultured fibroblasts (33, 43, 50). Although
p36 may not precisely co-localize with the spectrinlikeprotein,
it is seen in the same cortical region and stains in the same
type ofreticular pattern in fibroblasts (33, 43, 50). Our finding
that p36 localizes like the spectrin related protein TW 260/
240 in small intestine, provides more evidence for a cortical
localization of p36. The brush border is an amenable system
for studying the possible associations of p36 with the plasma
membrane or with other proteins closely apposed to the
membrane since it is easily separated from the rest of the cell.
Studies on the interactions of p36 in brush borders are un-
derway.
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